268
Views
0
CrossRef citations to date
0
Altmetric
Abstracts

Subject Index to Abstracts

Pages 575-578 | Published online: 16 Aug 2004

Abrin, 3

Acetaminophen, 77–79, 80, 81, 82, 89, 128, 163, 168, 197, 230–234

Acetylcysteine, 67

Activated charcoal, 6, 137, 214, 231

Adolescence, 165, 222

Alcohol dependence, 78

Aloe vera, 227

Amanita, 68, 149, 186, 187

Amanita phalloides, 187

Amanita proxima, 186

Amanita regalis, 149

Amatoxin, 66, 67, 70

Amiodarone, 209

Ammonaemia, 229

Ammonium bifluoride, 104

Analgesics, 163, 178

Antibiotics, 117, 208

Anticonvulsants, 12, 56, 153, 202, 214, 224, 229

Antidepressants, 92, 109, 121, 132, 136, 179

Antidotes, 8, 9, 13, 28, 66, 67, 72, 100, 120, 139, 172, 215

Antiepileptics, 88

Antimalarials, 73, 134

Antipsychotics, 46, 87, 110, 142

Antivenom, 210

Arsenic, 25, 36

Azaleptine, 142

B

Barbiturates, 159

Benzodiazepines, 215

Beta blockers, 83, 143, 158

Betaxolol, 150

Biological weapons, 48

Bites and stings, 154, 177, 194, 210

Bittering agents, 118

Body packing, 40

Brown fly agaric, 149

Buprenorphine, 204, 215

Butane, 97

C

Cade oil, 107

Calcium channel blockers, 158, 225

Calcium chloride, 225

Car batteries, 169

Carbamazepine, 153, 202

Carbon monoxide, 58–62, 64, 190, 191

Carcinogenicity, 99

Cardiac pacing, 37

Cardiotoxicity, 37, 75, 148, 150, 199, 203, 209, 224

Carvedilol, 143

Catecholamines, 34, 75

Charcoal haemoperfusion, 30

Chemical burns, 17, 22

Chemical weapons, 20, 48, 95, 101

Chemicals, 93, 114

Chloral hydrate, 209

Chloroquine, 73, 134

Cholinesterase inhibitors, 139, 208

Chromium, 152

Clozapine, 87, 142

Cocaine, 40, 141, 200, 219

Co‐proxamol, 89

Correctional facilities, 160

Corrosives, 17–19, 103

Criminal poisoning, 164

CS gas, 207

Curriculum, 131

Cyanide, 15, 193

Cyclooxygenase inhibitors, 232

D

Dapsone, 222

Decongestants, 86

Denatonium benzoate, 118

Dextropropoxyphene, 89

Diazinon, 155

Digoxin, 72, 203

Dihydrocodeine, 197

Dinitrophenol, 205

Dipyridamole, 140

DNA profiling, 188

Donepezil, 139, 208

Drug interactions, 208

Drugs of abuse, 9, 10, 40, 55, 91, 97, 115, 141, 151, 197, 200, 201, 217, 219, 235

E

Ecstasy (MDMA), 201

Elderly, 175

Elimination, 16, 68

Ephedra, 105, 176

Epidemiology, 51, 52, 55, 69, 93, 116, 120, 123, 125, 128, 132, 133, 138, 144, 145, 148, 157, 162–166, 170, 173–175, 177, 178, 182, 185, 189, 190, 194, 212

Escitalopram, 121

Essential oils, 107

Ethanol, 79, 81, 86, 111

Ethyl glucuronide, 96

Ethylene glycol, 100

Extracorporeal elimination, 36

F

Fab, 72

Flecainide, 90

Flumazenil, 11

Fluoride, 98

Fomepizole, 28

Food chain, 117

Forced alkaline diuresis, 159

Forced diuresis, 152

G

Gamma hydroxybutyrate (GHB), 91

Glucagon, 33

Glucose, 33

Growth promoters, 117

Gut decontamination, 84, 170

H

Haemodialysis, 28, 29, 39, 152, 159, 223, 229

Haemofiltration, 39

Haemoperfusion, 31

Hepatotoxicity, 31, 78, 80, 81, 125, 126, 234

Herbal, 105, 126, 174, 176, 221

Hydrocarbons, 183

Hydrofluoric acid, 21, 22

Hyperammonaemia, 106

Hyperbaric oxygen, 62, 63

Hypernatraemia, 112

Hypersensitivity syndrome, 222

Hypotension, 34

I

Infliximab, 113

Information resources, 43, 57, 124, 171

Insulin, 33, 122, 225

Intensive care, 32

Iron, 108, 130

L

Laboratory, 100, 187, 191

Lactation, 114

Lactic acidosis, 205

Lamp oil, 27, 94

Lead, 196, 212

Leprosy, 222

Levofloxacin, 208

Lipoid pneumonitis, 227

Lithium, 132, 179

Louis Roche lecture, 16

Lung injury, 4

M

Magic mushrooms, 69

Magnesium hydroxide, 223

Media activity, 115

Medication error, 129

Membrane stabilising agents, 35, 85

Methamphetamine, 217

Methanol, 28, 29, 100, 184, 192

Methemoglobinaemia, 226

Metoclopramide, 226

Multiple dose activated charcoal, 214

Muscle damage, 74

Mushrooms, 65, 66, 68–70, 123, 149, 157, 186–189

Mutagenicity, 99

N

Naloxone, 8, 9

Naltrexone, 141

Nephrotoxicity, 125, 186, 220

Nerve agents, 1, 2

Nicotine, 111

NSAIDs, 182, 195

O

Obidoxime, 24

Occupational, 26, 27, 98, 99

Ocular injuries, 23, 169

Olanzapine, 146

Opioids, 10, 115, 141, 197

Organ transplant, 41

Organophosphates, 24, 71, 155

Oximes, 14, 24, 71

Oxycodone, 115

P

Packaging, 118, 128, 182, 183

Paediatrics, 36, 51, 63, 118, 130, 133, 157, 165, 166, 168, 182, 191, 222, 230

Paracetamol, 77–82, 89, 128, 163, 168, 197, 230–234

Perchlorethylene, 213

Peripheral cardiocirculatory assistance, 35

Pesticides, 14, 24, 71, 155, 181

Petrochemicals, 99

Phencyclidine (PCP), 151, 235

Phentolamine, 200

Phenytoin, 214

Physostigmine, 13, 146

Plant exposures, 65, 66, 68, 70, 123, 144, 149, 174, 186–188

Pneumonia, 94, 216

Pneumonitis, 156

Poisons services, 7, 42, 44, 47, 49, 50, 57, 118, 124, 128, 135, 160, 162, 171, 228

Post mortem markers, 96

Potassium dichromate, 152

Pralidoxime, 139

Pre‐ & peri hospital care, 6–15, 83, 137, 138, 172

Pregnancy, 26, 63, 82, 88, 108, 114, 196, 198, 207, 213

Product identification, 53

Pseudohyperchloraemia, 211

Pseudolymphoma syndrome, 202

Psychotropic drugs, 216

Public health, 47, 49, 228

Q

Quetiapine, 46, 110

Quinidine, 225

R

Reprotoxicity, 99

Respiratory, 38, 45

Rhabdomyolysis, 74

Ricin, 3

Rizatriptan, 220

S

S100B protein, 60

Salicylate, 218

Scolopendra subspinipes, 154

Scorpions, 177, 194

Sexual assault, 161

Silicone, 156

Snake bite, 76, 210

Sodium bromide, 211

Sodium chloride, 112

Sotalol, 158

Steroids, 17, 19

Sulphur mustard, 5, 20, 95, 101

Surveillance, 42, 44, 49, 178

Synephrine, 221

T

Terrorism, 1–5, 43, 48

Tetraethyl lead, 102

Thrombocytopenia, 113

Tiagabine, 56

Tobacco, 198

Topiramate, 180

Training, 131, 167

Trazodone, 109

Tricyclic antidepressants, 92

V

Valproate, 54, 106, 224, 229

Verapamil, 158, 225

Veterinary poisoning, 185

Veterinary products, 211

Vietnamese centipede, 154

Vipera berus, 76

Vipera palaestinae, 210

W

Waterproofing products, 45

X

Xylometazoline, 86

Z

Zinc hexafluorosilicate, 147

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.